StocksDeepDive
Snapshot · Foreign US-listed · generated 2026-11-11 20:45 UTC

GSK — GSK plc

UNDERVALUED (MOS +25.2%) · Quality 61/100

Price
50.58
Intrinsic value
67.64
Margin of safety
+25.2%
Implied growth (reverse DCF)
-0.7%
model assumes +3.0%
Value Score
34.4
Quality
61
Psychology
-0.8
Discovery
5.7
price/volume attention only
Moat score
95
erosion: none

Value Score: top 49% of Foreign US-listed · Quality: bottom 48%

Dividend: 1.816/share (TTM) · yield 3.6% · payout 63%

Open the interactive Deep Dive for GSK →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/GSK - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is GSK undervalued?

As of 2026-11-11, GSK trades at 50.58 against a computed intrinsic value of 67.64 (+25.2% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is GSK plc's Value Score?

GSK plc's Value Score is 34.4 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does GSK pay a dividend?

Yes - GSK's trailing twelve-month dividend is 1.816/share, a yield of 3.6% at the current price (as of 2026-11-11).